About this trial
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a clinical syndrome in which patients report symptoms of bladder and/or pelvic pain with pressure and/ or discomfort associated with urinary frequency and urgency.
The primary objective of this study is to determine the efficacy of amniotic membrane therapy in patients with interstitial cystitis/painful bladder syndrome (IC/PBS) as defined by clinically-significant improvement in validated symptom questionnaires.
Eligibility criteria
Qualifiers
Patients 18 years of age or older
Female
English Speaking
Diagnosis of IC/PBS
Disqualifiers
Patients less than 18 years of age
Unable to provide consent
Non-English speaking
Patients with known anatomical malformations of the ureters, bladder, or urethra
Trial design
Treatments tested in this trial
- Clarix Flo
- Placebo
Treatment groups
Locations
1Sponsors and collaborators
David Sheyn
Lead sponsor
University Hospitals Cleveland Medical Center
Sponsor institution